NM_000062.3:c.1030-1222A>G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000062.3(SERPING1):​c.1030-1222A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.212 in 152,194 control chromosomes in the GnomAD database, including 3,917 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.21 ( 3917 hom., cov: 32)

Consequence

SERPING1
NM_000062.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.44

Publications

17 publications found
Variant links:
Genes affected
SERPING1 (HGNC:1228): (serpin family G member 1) This gene encodes a highly glycosylated plasma protein involved in the regulation of the complement cascade. Its encoded protein, C1 inhibitor, inhibits activated C1r and C1s of the first complement component and thus regulates complement activation. It is synthesized in the liver, and its deficiency is associated with hereditary angioneurotic oedema (HANE). Alternative splicing results in multiple transcript variants encoding the same isoform. [provided by RefSeq, May 2020]
SERPING1 Gene-Disease associations (from GenCC):
  • hereditary angioedema with C1Inh deficiency
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • C1 inhibitor deficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary angioedema type 1
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary angioedema type 2
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 11-57610495-A-G is Benign according to our data. Variant chr11-57610495-A-G is described in ClinVar as Benign. ClinVar VariationId is 983232.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.271 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000062.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SERPING1
NM_000062.3
MANE Select
c.1030-1222A>G
intron
N/ANP_000053.2
SERPING1
NM_001032295.2
c.1030-1222A>G
intron
N/ANP_001027466.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SERPING1
ENST00000278407.9
TSL:1 MANE Select
c.1030-1222A>G
intron
N/AENSP00000278407.4
SERPING1
ENST00000619430.2
TSL:1
c.826-1222A>G
intron
N/AENSP00000478572.2
SERPING1
ENST00000531133.5
TSL:1
n.*399-1222A>G
intron
N/AENSP00000435431.1

Frequencies

GnomAD3 genomes
AF:
0.212
AC:
32236
AN:
152076
Hom.:
3917
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.104
Gnomad AMI
AF:
0.248
Gnomad AMR
AF:
0.181
Gnomad ASJ
AF:
0.289
Gnomad EAS
AF:
0.113
Gnomad SAS
AF:
0.184
Gnomad FIN
AF:
0.311
Gnomad MID
AF:
0.231
Gnomad NFE
AF:
0.274
Gnomad OTH
AF:
0.231
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.212
AC:
32234
AN:
152194
Hom.:
3917
Cov.:
32
AF XY:
0.213
AC XY:
15821
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.104
AC:
4305
AN:
41536
American (AMR)
AF:
0.181
AC:
2765
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.289
AC:
1002
AN:
3472
East Asian (EAS)
AF:
0.113
AC:
584
AN:
5184
South Asian (SAS)
AF:
0.183
AC:
884
AN:
4818
European-Finnish (FIN)
AF:
0.311
AC:
3294
AN:
10598
Middle Eastern (MID)
AF:
0.241
AC:
71
AN:
294
European-Non Finnish (NFE)
AF:
0.274
AC:
18614
AN:
67980
Other (OTH)
AF:
0.232
AC:
489
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1288
2575
3863
5150
6438
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
348
696
1044
1392
1740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.235
Hom.:
2562
Bravo
AF:
0.196
Asia WGS
AF:
0.155
AC:
536
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary angioedema type 1 Benign:1
CeMIA
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: allele frequency is >5% in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium (BA1), allele frequency is greater than expected for disorder (BS1), it is observed in a healthy adult individual (BS2), it is predicted to be benign by multiple in silico algorithms (BP4), it is found in a case with an alternate molecular basis for the disease (BP5) and/or reputable source recently reports variant as benign (BP6).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.15
DANN
Benign
0.38
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3824988; hg19: chr11-57377968; API